CommentaryPolicy

Taking Risks with Translational Research

See allHide authors and affiliations

Science Translational Medicine  24 Mar 2010:
Vol. 2, Issue 24, pp. 24cm10
DOI: 10.1126/scitranslmed.3000667

Article Information

vol. 2 no. 24 24cm10

DOI: 
https://doi.org/10.1126/scitranslmed.3000667
PubMed: 
20375005
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2010, American Association for the Advancement of Science

Author Information

  1. Ian G. Mills1,* and
  2. Richard B. Sykes2
  1. 1Uro-Oncology Research Group, Cancer Research UK Cambridge, Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Norwegian Centre for Molecular Medicine, Nordic EMBL Partnership, University of Oslo, Blindern N-0317 Oslo, Norway.
  2. 2NHS London, Southside, 105 Victoria Street, London SW1E 6QT, UK.
  1. *Corresponding author. E-mail: ian.mills{at}cancer.org.uk

Altmetric

Article usage

Article usage: March 2010 to January 2021

AbstractFullPdf
Mar 20101987347141
Apr 201070912588
May 20101742829
Jun 20101243722
Jul 20101021018
Aug 20101001918
Sep 2010574521
Oct 2010854823
Nov 201052279
Dec 201063911
Jan 2011771813
Feb 2011442422
Mar 2011563541
Apr 201134179
May 2011321019
Jun 2011731315
Jul 20114087
Aug 201191153
Sep 201142010
Oct 20112625
Nov 20112333
Dec 20112862
Jan 20121914
Feb 20121033
Mar 20123422
Apr 20122064
May 20124444
Jun 20121111
Jul 20121612
Aug 20123211
Sep 20122126
Oct 20122211
Nov 20123522
Dec 20124912
Jan 201331125
Feb 201340282
Mar 201332232
Apr 201339275
May 201352313
Jun 201380313
Jul 201332314
Aug 201321353
Sep 201322302
Oct 201338429
Nov 201318374
Dec 2013173321
Jan 2014353821
Feb 201431366
Mar 201436347
Apr 201427388
May 201411363
Jun 201411331
Jul 2014293511
Aug 201415377
Sep 20148294
Oct 201412357
Nov 20145304
Dec 2014123716
Jan 2015426119
Feb 20159325
Mar 20158337
Apr 201517395
May 201524474
Jun 201517214
Jul 201516122
Aug 201525213
Sep 201510254
Oct 2015553
Nov 20151231
Dec 2015964
Jan 2016986
Feb 2016231122
Mar 201622127
Apr 20169284
May 201623482
Jun 2016345813
Jul 201619445
Aug 2016155212
Sep 2016154414
Oct 2016204310
Nov 201622433
Dec 201614484
Jan 201713543
Feb 201718435
Mar 201720391
Apr 201712422
May 201721463
Jun 201716404
Jul 201729174
Aug 201729135
Sep 201740136
Oct 201730257
Nov 2017281919
Dec 2017291713
Jan 2018251211
Feb 201820113
Mar 2018182012
Apr 201827257
May 2018353020
Jun 2018493532
Jul 2018182313
Aug 2018013910
Sep 201817318
Oct 201806910
Nov 201811107
Dec 201809010
Jan 20193617
Feb 201910667
Mar 20194225
Apr 20195225
May 20196156
Jun 20197173
Jul 20196295
Aug 20190217
Sep 201958919
Oct 20193238
Nov 20192197
Dec 20194196
Jan 20204217
Feb 20205255
Mar 20204167
Apr 20201233
May 20202154
Jun 20202173
Jul 20202121
Aug 20201162
Sep 20207194
Oct 20203319
Nov 20201199
Dec 20204394
Jan 20211131

View Full Text

Article Tools

  • Email
  • Download Powerpoint
  • Print

  • Alerts
  • Citation tools

  • Taking Risks with Translational Research

    By Ian G. Mills, Richard B. Sykes

    Science Translational Medicine : 24cm10

    The private sector should undertake the high-throughput elements of translational research, while the public sector funds the development of scientists with the confidence to attempt to translate genetic data into a mechanistic understanding of complex diseases.

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

My saved folders

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article